{
    "Orphapacket": {
        "ORPHApacketId": "119",
        "creationDate": "2020-12-03 15:53:15",
        "version": "1.3.6 / 4.1.7 [2020-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2020",
        "ORPHAcode": "119",
        "Label": "Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_119",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Autosomal recessive limb-girdle muscular dystrophy type 2E"
            },
            {
                "Synonym": "Beta-sarcoglycan-related LGMD R4"
            },
            {
                "Synonym": "Beta-sarcoglycanopathy"
            },
            {
                "Synonym": "LGMD due to beta-sarcoglycan deficiency"
            },
            {
                "Synonym": "LGMD type 2E"
            },
            {
                "Synonym": "LGMD2E"
            },
            {
                "Synonym": "Limb-girdle muscular dystrophy due to beta-sarcoglycan deficiency"
            },
            {
                "Synonym": "Limb-girdle muscular dystrophy type 2E"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "604286",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A subtype of autosomal recessive limb girdle muscular dystrophy characterized by a childhood to adolescent onset of progressive pelvic- and shoulder-girdle muscle weakness particularly affecting the pelvic girdle (adductors and flexors of hip). Usually the knees are the earliest and most affected muscles. In advanced stages involvement of the shoulder girdle (resulting in scapular winging) and the distal muscle groups are observed. Calf hypertrophy cardiomyopathy respiratory impairment tendon contractures scoliosis and exercise-induced myoglobinuria may be observed."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "SGCB",
                    "Name": "sarcoglycan beta",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "207063",
                        "Label": "Qualitative or quantitative defects of beta-sarcoglycan"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "102015",
                        "Label": "Autosomal recessive limb-girdle muscular dystrophy"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "217610",
                        "Label": "Neuromuscular disease with dilated cardiomyopathy"
                    }
                ]
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0000750",
                    "HPOTerm": "Delayed speech and language development",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002058",
                    "HPOTerm": "Myopathic facies",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002136",
                    "HPOTerm": "Broad-based gait",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002355",
                    "HPOTerm": "Difficulty walking",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002515",
                    "HPOTerm": "Waddling gait",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0003198",
                    "HPOTerm": "Myopathy",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0003236",
                    "HPOTerm": "Elevated serum creatine kinase",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0003391",
                    "HPOTerm": "Gowers sign",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0003557",
                    "HPOTerm": "Increased variability in muscle fiber diameter",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0003749",
                    "HPOTerm": "Pelvic girdle muscle weakness",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0008981",
                    "HPOTerm": "Calf muscle hypertrophy",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001638",
                    "HPOTerm": "Cardiomyopathy",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002913",
                    "HPOTerm": "Myoglobinuria",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "19767415[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "United Kingdom"
                }
            },
            {
                "Prevalence": {
                    "Source": "European Medicines Agency 2011[INST]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            }
        ],
        "AverageAgeOfDeaths": {
            "AverageAgeOfDeath": [
                {
                    "value": "adult"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}